JP2008105984A - Collagen production promoter, skin care preparation for external use, bathing agent, and food and drink - Google Patents

Collagen production promoter, skin care preparation for external use, bathing agent, and food and drink Download PDF

Info

Publication number
JP2008105984A
JP2008105984A JP2006289308A JP2006289308A JP2008105984A JP 2008105984 A JP2008105984 A JP 2008105984A JP 2006289308 A JP2006289308 A JP 2006289308A JP 2006289308 A JP2006289308 A JP 2006289308A JP 2008105984 A JP2008105984 A JP 2008105984A
Authority
JP
Japan
Prior art keywords
skin
extract
collagen production
production promoter
extracts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006289308A
Other languages
Japanese (ja)
Inventor
Ikuo Kameoka
郁雄 亀岡
Yuki Inoue
有希 井上
Junko Okuno
純子 奥野
Kiyoshi Sugiyama
清 杉山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nicca Chemical Co Ltd
Original Assignee
Nicca Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicca Chemical Co Ltd filed Critical Nicca Chemical Co Ltd
Priority to JP2006289308A priority Critical patent/JP2008105984A/en
Publication of JP2008105984A publication Critical patent/JP2008105984A/en
Withdrawn legal-status Critical Current

Links

Abstract

<P>PROBLEM TO BE SOLVED: To provide a collagen production promoter that causes a skin fibroblast to produce collagen which exerts large influences on elasticity and tightness of the skin, and to provide a skin care preparation for external use, a bathing agent, and foods and drinks that comprise the collagen production promoter and exhibit effects of improving tightness of the skin and wrinkles. <P>SOLUTION: The collagen production promoter comprises one or two or more selected from among Sophora flavescens extracts, Polygala tenuifolia extracts, Diospyros kaki extracts, Salvia miltiorrhiza extracts, Peonia lactiflora extracts, puer extracts, arbutin, and oligosaccharide alginates. The skin care preparation for external use, the bathing agent, and foods and drinks comprise the collagen production promoter and exhibit effects of improving tightness of the skin and wrinkles. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

本発明は、皮膚の弾力、張り、潤いに重要な役割を担うコラーゲンの産生促進剤に関する。更には、コラーゲン産生促進剤を含有する皮膚外用剤、浴用剤及び飲食物に関する。   The present invention relates to a collagen production promoter that plays an important role in skin elasticity, tension and moisture. Furthermore, it is related with the skin external preparation, the bath preparation, and food and drink containing a collagen production promoter.

近年、高齢化社会や女性の社会進出にともない、美容に対する意識が向上している。しかし、皮膚の機能は年齢と共に低下し、老化により弾力や張りを失い、しわが生じてくる。この原因として、皮膚中に存在するコラーゲンとヒアルロン酸の量の低下があげられる。   In recent years, beauty awareness has increased with the aging of society and the advancement of women in society. However, the function of the skin decreases with age, and aging causes loss of elasticity and tension and wrinkles. This is due to a decrease in the amount of collagen and hyaluronic acid present in the skin.

皮膚は、皮下組織、真皮、表皮の三層から成っていて、皮膚の弾力など皮膚の機能に最も影響を与えているのが真皮であり、この真皮にはコラーゲンとヒアルロン酸が多く含まれている。これらコラーゲンとヒアルロン酸は、真皮中に存在する皮膚線維芽細胞が産生することが知られており、皮膚の弾力性の保持に重要な役割を担っている。
コラーゲンは人のタンパク質全体の約30%を占めており、そのうち真皮には約70%が存在する。コラーゲンは細胞をつなぎとめる働きをしているが、これが老化にともない減少していくことから、皮膚にしわやたるみが発生すると考えられている。
The skin consists of three layers: the subcutaneous tissue, the dermis, and the epidermis. The dermis has the most influence on the skin's functions, such as the elasticity of the skin. This dermis is rich in collagen and hyaluronic acid. Yes. These collagens and hyaluronic acid are known to be produced by dermal fibroblasts present in the dermis and play an important role in maintaining the elasticity of the skin.
Collagen accounts for approximately 30% of human protein, of which approximately 70% is present in the dermis. Collagen works to hold cells together, but it decreases with age, and it is thought that wrinkles and sagging occur in the skin.

さらに従来コラーゲンは、様々な結合組織に、力学的な強度を与えることに重要な役割を果たすことや、現在では、細胞の代謝、形態、増殖、分化、移動などの様々な活動に影響を与えることが知られており、線維芽細胞などの細胞におけるコラーゲン産生量を調節することによる、膠原病等の治療、ケロイドの予防、皮膚老化の予防への応用が期待されている。   Furthermore, conventional collagen plays an important role in giving mechanical strength to various connective tissues, and currently affects various activities such as cell metabolism, morphology, proliferation, differentiation, and migration. It is known that it is expected to be applied to the treatment of collagen diseases, the prevention of keloids, and the prevention of skin aging by regulating the amount of collagen production in cells such as fibroblasts.

皮膚のしわの改善や皮膚の弾力を増進する化粧料として、特許文献1には、有効成分としてレチノールを含有する化粧料が開示されている。また、ケラチン物質(皮膚等)のケア等に使用する組成物として、特許文献2には、親油性活性剤を含むナノカプセルが開示されている。   As cosmetics for improving skin wrinkles and improving skin elasticity, Patent Document 1 discloses cosmetics containing retinol as an active ingredient. Further, Patent Document 2 discloses a nanocapsule containing a lipophilic active agent as a composition used for the care of keratin substances (skin etc.).

しかし、特許文献1又は2に記載のレチノールや親油性活性剤は、皮膚刺激性が強く、また不安定な物質であるため特殊な製剤化技術を必要とする。さらに特許文献1及び2には、クララエキス等の特定の植物エキス、又はアルブチン等の特定の化合物が、コラーゲン産生を促進し、皮膚の老化を防止する点については何も開示していない。
特開2003−81737公報 特開2003−292420公報
However, the retinol and lipophilic active agent described in Patent Document 1 or 2 have strong skin irritation and are unstable substances, and therefore require special formulation techniques. Furthermore, Patent Documents 1 and 2 disclose nothing about the fact that specific plant extracts such as Clara extract or specific compounds such as arbutin promote collagen production and prevent skin aging.
JP 2003-81737 A JP 2003-292420 A

本発明は、肌の弾力や張りに大きく影響し、若々しい肌を保つ上で重要なコラーゲンを皮膚線維芽細胞に産出させるコラーゲン産生促進剤、及び該コラーゲン産生促進剤を配合した肌の張り及びしわの改善効果を有する組成物を提供することを目的としてなされたものである。   The present invention relates to a collagen production promoter that greatly affects the elasticity and tension of the skin and produces collagen that is important in maintaining youthful skin to the skin fibroblasts, and the skin tension containing the collagen production promoter. And an object of the present invention is to provide a composition having an effect of improving wrinkles.

本発明者らは、上記課題を解決するために鋭意研究を重ねた結果、特定の植物エキス、アルブチン及びアルギン酸オリゴ糖類がコラーゲンの産生を促進する作用を有することを見出し、この知見に基づき本発明を完成させた。   As a result of intensive studies to solve the above problems, the present inventors have found that specific plant extracts, arbutin and alginic acid oligosaccharides have an action of promoting collagen production. Was completed.

すなわち、本発明は、クララエキス、イトヒメハギエキス、カキエキス、タンジンエキス、シャクヤクエキス、プーアルエキス、アルブチン及びアルギン酸オリゴ糖類から選ばれる1種又は2種以上を含有することを特徴とするコラーゲン産生促進剤を提供する。
更に、本発明は、前記コラーゲン産生促進剤を含有することを特徴とする皮膚外用剤、浴用剤又は飲食物を提供する。
That is, the present invention comprises a collagen production promoter characterized by containing one or more selected from a clara extract, a citrus extract, a oyster extract, a tanjin extract, a peony extract, a puer extract, an arbutin, and an alginate oligosaccharide. I will provide a.
Furthermore, this invention provides the skin external preparation, the bath preparation, or food-drinks characterized by including the said collagen production promoter.

本発明のクララエキス、イトヒメハギエキス、カキエキス、タンジンエキス、シャクヤクエキス、プーアルエキス、アルブチン及びアルギン酸オリゴ糖類から選ばれる1種又は2種以上を有効成分として含有するコラーゲン産生促進剤は、皮膚の線維芽細胞においてコラーゲン産生の促進効果を有する。これらのコラーゲン産生促進剤は、皮膚における線維芽細胞のコラーゲン量を多くすることができるので、結果として、肌のしわやたるみを改善することができ、抗老化化粧料、抗老化浴用剤及び抗老化飲食物の有効成分としての利用が期待できる。   Collagen production promoter containing, as an active ingredient, one or more selected from the clara extract, citrus extract, oyster extract, tanjin extract, peony extract, puer extract, arbutin and alginic acid oligosaccharide of the present invention is a skin fiber Has an effect of promoting collagen production in blast cells. These collagen production promoters can increase the amount of fibroblast collagen in the skin, and as a result, can improve skin wrinkles and sagging, anti-aging cosmetics, anti-aging bath agents and anti-aging bath agents. Use as an active ingredient of aging foods and drinks can be expected.

本発明のコラーゲン産生促進剤は、クララエキス、イトヒメハギエキス、カキエキス、タンジンエキス、シャクヤクエキス、プーアルエキス、アルブチン及びアルギン酸オリゴ糖類から選ばれる1種又は2種以上を含有することを特徴とするものである。   The collagen production promoter of the present invention is characterized by containing one or more selected from Clara extract, Cyprinus extract, oyster extract, Tanjin extract, peony extract, Puaru extract, arbutin and alginic acid oligosaccharide. It is.

前記植物エキス、アルブチン及びアルギン酸オリゴ糖類から選ばれる2種以上含有する本発明のコラーゲン産生促進剤としては、
クララエキスとアルギン酸オリゴ糖類、アルブチン、イトヒメハギエキス、カキエキス、シャクヤクエキス、タンジンエキス、又はプーアルエキスとの組み合わせ;
イトヒメハギエキスとアルブチン、シャクヤクエキス、カキエキス、タンジンエキス、プーアルエキス、又はアルギン酸オリゴ糖類との組み合わせ;
クララエキス、イトヒメハギエキス、及びアルギン酸オリゴ糖類の組み合わせ;
イトヒメハギエキス、アルブチン、及びシャクヤクエキスの組み合わせ;
イトヒメハギエキス、アルブチン、及びカキエキスの組み合わせ;
から選ばれる組み合わせを含有するものが、肌のしわやたるみの改善作用に特に優れることから好ましい。
As the collagen production promoter of the present invention containing two or more selected from the plant extract, arbutin and alginic acid oligosaccharides,
A combination of Clara extract and alginate oligosaccharide, arbutin, Itohime extract, oyster extract, peonies extract, tanjin extract, or puer extract;
A combination of Itohime extract and arbutin, peony extract, oyster extract, tanjin extract, puer extract, or alginate oligosaccharides;
A combination of Clara extract, Cypress extract, and alginate oligosaccharides;
A combination of Itohimehagi extract, arbutin, and peony extract;
A combination of Itohime extract, arbutin, and oyster extract;
Those containing a combination selected from the above are preferred because they are particularly excellent in the action of improving wrinkles and sagging of the skin.

本発明で使用するクララエキスとは、マメ科植物のクララの根を用いて抽出するが、地上部さらに同属植物を用いて抽出することができる。   The Clara extract used in the present invention is extracted by using the roots of the leguminous plant Clara, but can be extracted by using the above-mentioned part and a plant belonging to the same genus.

本発明で使用するイトヒメハギエキスとは、ヒトハギ科植物のイトヒメハギの根を用いて抽出するが、地上部さらに同属植物を用いて抽出することができる。   The extract of Itohimehae used in the present invention is extracted using the root of Itohimehagi, which is a plant belonging to the human family, but can also be extracted using the above-mentioned genus plant.

本発明で使用するカキエキスとは、カキノキ科植物のカキの葉を用いて抽出するが、地上部さらに同属植物を用いて抽出することができる。   The oyster extract used in the present invention is extracted using oyster leaves of a cynoaceae plant, but can be extracted using the above-mentioned part and a genus plant.

本発明で使用するタンジンエキスとは、シソ科植物のタンジンの根を用いて抽出するが、地上部さらに同属植物を用いて抽出することができる。   The tanjin extract used in the present invention is extracted using roots of tannins of Labiatae plants, but can be extracted using the above-ground parts and the same genus plants.

本発明で使用するシャクヤクエキスとは、ボタン科植物のシャクヤクの根の外皮を除去したものを用いて抽出するが、地上部さらに同属植物を用いて抽出することができる。   The peony extract used in the present invention is extracted using a peony root that has been removed from the peony root, but can be extracted from the above-ground part and a plant belonging to the same genus.

本発明で使用するプーアルエキスとは、ツバキ科植物のチャの葉を黒麹菌などで後発酵させたもの、いわゆるプーアルの葉を用いて抽出する。   The puer extract used in the present invention is extracted by using a so-called puer leaf obtained by post-fermenting tea leaves of a camellia plant with black koji mold or the like.

本発明において、クララエキス、イトヒメハギエキス、カキエキス、タンジンエキス、シャクヤクエキス、プーアルエキスなどの植物エキスとしては、上記の各植物の各種部位を未乾燥のまま又は乾燥させた後そのままに、あるいは、破砕又は粉砕後に搾取して使用することができる。さらに、これらを溶媒で抽出して得られるエキスや、該エキスから抽出溶媒を蒸発又は凍結乾燥して得られる不揮発分を使用することができる。   In the present invention, as a plant extract such as Clara extract, citrus extract, oyster extract, tanjin extract, peony extract, puer extract, etc. It can be used after being crushed or ground. Furthermore, the extract obtained by extracting these with a solvent, and the non-volatile content obtained by evaporating or lyophilizing the extraction solvent from the extract can be used.

ここで用いられる抽出溶媒としては、水、メタノール、エタノール、エチレングリコール、プロピレングリコール、1,3−ブチレングリコールなどの低級アルコール類、アセトンなどのケトン類、酢酸エチルなどのエステル類、ジエチルエーテルなどのエーテル類、トルエンなどの芳香族類等の各種の溶媒が挙げられ、単独又は2種以上の溶媒を任意に組み合わせて使用することができる。   Examples of the extraction solvent used herein include water, lower alcohols such as methanol, ethanol, ethylene glycol, propylene glycol, and 1,3-butylene glycol, ketones such as acetone, esters such as ethyl acetate, and diethyl ether. Various solvents, such as ethers and aromatics, such as toluene, are mentioned, It can use individually or in combination of 2 or more types.

本発明で使用するアルブチンとは、コケモモ、ウワウルシ、ナシなどの植物に含まれる天然型(β−グルコシド型)の配糖体であり、化学名が4−ヒドロキシフェニル−β−D−グルコシピラノシドのものを用いることができる。   Arbutin used in the present invention is a natural type (β-glucoside type) glycoside contained in plants such as cowberry, walrus, and pear, and has a chemical name of 4-hydroxyphenyl-β-D-glucosipyrano. Sid's can be used.

本発明で使用するアルギン酸オリゴ糖類とは、高分子アルギン酸又は高分子アルギン酸塩(ナトリウム塩、マグネシウム塩、カリウム塩など)を低分子化し、分子量を2000〜20000に調製したものを用いることが好ましい。そして、その分解方法については、酸又はアルカリ分解、酵素分解、熱分解などの方法で良く、その手法は問わず、また、高分子アルギン酸を低分子アルギン酸とした後、低分子アルギン酸塩にしたものでも良い。   As the alginate oligosaccharide used in the present invention, it is preferable to use a polymer alginic acid or a polymer alginate (sodium salt, magnesium salt, potassium salt, etc.) whose molecular weight is adjusted to 2000-20000. The decomposition method may be acid or alkali decomposition, enzymatic decomposition, thermal decomposition, etc., regardless of the method, and after converting high molecular alginic acid to low molecular alginic acid, low molecular alginate is used. But it ’s okay.

本発明で使用される植物エキスは、医薬又は民間薬、食品、化粧品の成分として一般的に用いられるものであり、その安全性が確認されているものである。   The plant extract used in the present invention is generally used as a component of medicines or folk medicines, foods and cosmetics, and its safety has been confirmed.

本発明のコラーゲン産生促進剤は、前記植物エキス、アルブチン及びアルギン酸オリゴ糖類から選ばれる1種又は2種以上を含有し、コラーゲン産生促進剤への総配合量はその剤型によっても異なるものであり、蒸発残分をそのまま使用しても構わないし、目的用途によって適宜、配合量を調整すればよく、また、本発明のコラーゲン産生促進剤の使用量にも特に制限はなく、用途や適用により適宜調整することができる。   The collagen production promoter of the present invention contains one or more selected from the above plant extracts, arbutin and alginic acid oligosaccharides, and the total amount added to the collagen production promoter varies depending on the dosage form. The evaporation residue may be used as it is, and the blending amount may be appropriately adjusted depending on the intended use. Also, the amount of the collagen production promoter of the present invention is not particularly limited, and is appropriately determined depending on the use and application. Can be adjusted.

本発明のコラーゲン産生促進剤は、外用又は内用素材への処理など様々な形態に適用できる。また、通常の外用又は内用素材への処理などで使用されている薬剤などとも組み合わせて使用することができ、併用薬剤により本発明の効果がより発現しやすくなる。   The collagen production promoter of the present invention can be applied to various forms such as treatment for external or internal materials. In addition, it can be used in combination with a drug used for treatment of ordinary external or internal materials, and the effect of the present invention is more easily exhibited by the combined drug.

本発明のコラーゲン産生促進剤は、医薬品、医薬部外品、局所又は全身用の皮膚化粧品、頭皮・頭髪に適用する薬用又は化粧用の製剤類をはじめとする各種の皮膚外用剤、浴用剤及び飲食物などに配合することができる。   Collagen production promoters of the present invention include pharmaceuticals, quasi-drugs, topical or systemic skin cosmetics, various skin external preparations such as medicinal or cosmetic preparations applied to the scalp / hair, bath preparations and It can mix | blend with food and drink.

本発明の皮膚外用剤、浴用剤及び飲食物は、前記コラーゲン産生促進剤の1種又は2種以上を含有する。そして前記コラーゲン産生促進剤の皮膚外用剤等への総配合量は、剤型により適宜異なるが、前記皮膚外用剤、浴用剤及び飲食物全体の質量に対し、一般的には、前記コラーゲン産生促進剤に含有される植物エキス、アルブチン及びアルギン酸オリゴ糖類の配合量に換算して、0.01質量%〜10質量%、好ましくは0.025質量%〜5質量%、さらに特定すると0.05質量%〜2.5質量%となるように含有することが望ましい。   The skin external preparation, bath preparation, and food and drink of the present invention contain one or more of the collagen production promoters. The total amount of the collagen production promoter to the skin external preparation or the like varies depending on the dosage form, but generally, the collagen production promotion is based on the mass of the skin external preparation, bath preparation, and overall food and drink. In terms of the amount of plant extract, arbutin and alginic acid oligosaccharide contained in the agent, 0.01% by mass to 10% by mass, preferably 0.025% by mass to 5% by mass, and more specifically 0.05% by mass. It is desirable to contain so that it may become% -2.5 mass%.

本発明の皮膚外用剤及び浴用剤には、前記コラーゲン産生促進剤の他に、通常の皮膚外用剤又は浴用剤において従来から使用されている公知の機能成分、例えば、保湿剤、エモリエント剤、血行促進剤、細胞賦活化剤、抗酸化剤、抗炎症剤、抗菌剤、美白剤、過酸化物抑制剤などを配合することができる。   The skin external preparation and bath preparation of the present invention include, in addition to the collagen production promoter, known functional components conventionally used in normal skin external preparations or bath preparations, such as moisturizers, emollients, blood circulations. Accelerators, cell activators, antioxidants, anti-inflammatory agents, antibacterial agents, whitening agents, peroxide inhibitors and the like can be blended.

公知の機能成分としてより具体的には、グリセリン、ブチレングリコール、尿素、アミノ酸類などの保湿剤;スクワラン、マカデミアナッツ油、オリーブ油、ホホバ油、シリコン油などのエモリエント剤;ビタミンE類、トウガラシチンキなどの血行促進剤;核酸などの細胞賦活化剤、ジブチルヒドロキシトルエン(BHT)、ジブチルヒドロキシアニソール(BHA)、酢酸トコフェロールなどの抗酸化剤;グリチルリチン、アラントインなどの抗炎症剤;ヒノキチオール、塩化ベンザルコニウム、クロルヘキシジン塩、パラヒドロキシ安息香酸エステルなどの抗菌剤;アスコルビン酸などの美白剤;スーパーオキシドジスムターゼ(SOD)などの過酸化物抑制剤など、種々の機能成分を配合することができる。
また、オウゴンエキス、イチョウエキス、胎盤抽出物、乳酸菌培養抽出物などの植物・動物・微生物由来の各種抽出物なども制限なく添加して使用することができる。
More specifically, known functional ingredients include humectants such as glycerin, butylene glycol, urea, and amino acids; emollients such as squalane, macadamia nut oil, olive oil, jojoba oil, and silicone oil; vitamin Es, pepper tincture, and the like. Blood circulation promoters; cell activators such as nucleic acids, antioxidants such as dibutylhydroxytoluene (BHT), dibutylhydroxyanisole (BHA), tocopherol acetate; anti-inflammatory agents such as glycyrrhizin and allantoin; hinokitiol, benzalkonium chloride, Various functional components such as antibacterial agents such as chlorhexidine salt and parahydroxybenzoate; whitening agents such as ascorbic acid; peroxide inhibitors such as superoxide dismutase (SOD) can be blended.
In addition, various extracts derived from plants, animals, and microorganisms such as hornon extract, ginkgo biloba extract, placenta extract, and lactic acid bacteria culture extract can be added and used without limitation.

本発明の皮膚外用剤とは、外用可能な剤であって、その剤型には特に制限はなく、例えば、ペースト剤、クリーム、ジェル、軟膏、ローション、乳液、パック、パウダー、ハップ剤などが例示できる。   The external preparation for skin of the present invention is an agent that can be applied externally, and there is no particular limitation on the dosage form, for example, paste, cream, gel, ointment, lotion, emulsion, pack, powder, haptic agent, etc. It can be illustrated.

本発明の浴用剤の剤型には特に制限はなく、例えば、粉末、顆粒状などの固形製剤、乳液、ペースト状などの液体製剤などが例示できる。   There is no restriction | limiting in particular in the dosage form of the bath preparation of this invention, For example, liquid preparations, such as solid preparations, such as a powder and a granular form, an emulsion, and a paste form, etc. can be illustrated.

本発明の飲食物には、前記コラーゲン産生促進剤の他に、通常食品に使用されている様々な材料を特に制限なく併用することができる。   In addition to the collagen production promoter, various materials that are usually used in foods can be used in combination with the food and drink of the present invention without any particular limitation.

本発明の飲食物の剤型としては適用可能なあらゆる形態があり、例えば、ビスケット、クッキー、錠剤、カプセル剤、キャンディー、ガム、粉末などの固形製剤、飲料などの液体製剤、ゼリーなどの半固形製剤などが例示できる。   The dosage form of the food and drink of the present invention includes all applicable forms, for example, solid preparations such as biscuits, cookies, tablets, capsules, candy, gum, and powder, liquid preparations such as beverages, and semisolids such as jelly Examples include preparations.

また、本発明の皮膚外用剤、浴用剤及び飲食物には、その剤型化のために界面活性剤、油脂類などの基材成分や、必要に応じて増粘剤、防腐剤、等張化剤、酸化防止剤、紫外線吸収剤、キレート剤、香料、着色料などの種々の添加物を併用できる。   In addition, the external preparation for skin, bath preparation and food and drink of the present invention include base ingredients such as surfactants and fats and oils, and thickeners, preservatives, isotonic agents as necessary. Various additives such as an agent, an antioxidant, an ultraviolet absorber, a chelating agent, a fragrance, and a coloring agent can be used in combination.

上記の界面活性剤として、特に限定されるものではないが、一般的な非イオン界面活性剤、陰イオン界面活性剤、陽イオン界面活性剤、両性界面活性剤を用いることができる。例えば、高級アルコールのアルキレンオキサイド付加物、高級アルキルアミンのアルキレンオキサイド付加物、高級脂肪酸のアルキレンオキサイド付加物、高級脂肪酸アミドのアルキレンオキサイド付加物、多価アルコールの脂肪酸エステル、硬化ひまし油のアルキレンオキサイド付加物、ポリエチレングリコールソルビタンアルキルエステル、ステロール等のアルキレンオキサイド付加物などの非イオン界面活性剤;アルキル硫酸ナトリウム、アルキロイルメチルタウリンナトリウム、α−オレフィンスルホン酸ナトリウム、ポリオキシアルキレンアルキルエーテル硫酸ナトリウムなどの陰イオン界面活性剤;塩化アルキルピリジニウム、塩化ジステアリルジメリルアンモニウムなどの陽イオン界面活性剤;アミノプロピオン酸ナトリウム、アルキルポリアミノエチルグリシンなどの両性界面活性剤が挙げられる。そして、これらの界面活性剤は1種又は2種以上を選択して使用することができる。   Although it does not specifically limit as said surfactant, A general nonionic surfactant, anionic surfactant, a cationic surfactant, and an amphoteric surfactant can be used. For example, alkylene oxide adduct of higher alcohol, alkylene oxide adduct of higher alkylamine, alkylene oxide adduct of higher fatty acid, alkylene oxide adduct of higher fatty acid amide, fatty acid ester of polyhydric alcohol, alkylene oxide adduct of hardened castor oil , Nonionic surfactants such as alkylene oxide adducts such as polyethylene glycol sorbitan alkyl esters and sterols; anions such as sodium alkyl sulfate, sodium alkylylmethyl taurate, sodium α-olefin sulfonate, sodium polyoxyalkylene alkyl ether sulfate Surfactants; Cationic surfactants such as alkylpyridinium chloride and distearyl dimerylammonium chloride; Sodium aminopropionate Amphoteric surfactants such as alkylpolyaminoethylglycine the like. And these surfactant can select and use 1 type (s) or 2 or more types.

本発明において使用可能な基材成分として、特に限定されるものではないが、例えば、オリーブ油、ツバキ油、アボカド油、マカデミアナッツ油、杏仁油、ホホバ油、スクワラン、スクワレン、馬油、パラフィン、シリコンなど、一般的に知られている油脂類が挙げられる。   The base component usable in the present invention is not particularly limited, and examples thereof include olive oil, camellia oil, avocado oil, macadamia nut oil, apricot oil, jojoba oil, squalane, squalene, horse oil, paraffin, silicon and the like. And generally known fats and oils.

本発明において使用可能な増粘剤として、特に限定されるものではないが、例えば、ポリビニルアルコール、ポリビニルアクリルアミド、ポリエチレングリコール、及びこれらの各種誘導体;ヒドロキシアルキルセルロースなどのセルロース類及びその誘導体;デキストラン、ゼラチン、アラビアガム、トラガントガムなどのガム類;カルボキシビニルポリマーなどの水溶性高分子などが挙げられる。   Although it does not specifically limit as a thickener which can be used in this invention, For example, polyvinyl alcohol, polyvinyl acrylamide, polyethyleneglycol, and these various derivatives; Celluloses, such as a hydroxyalkyl cellulose, and its derivative; Dextran, Examples include gums such as gelatin, gum arabic, and gum tragacanth; and water-soluble polymers such as carboxyvinyl polymer.

本発明において使用可能な防腐剤として、特に限定されるものではないが、例えば、パラヒドロキシ安息香酸エステル、パラオキシ安息香酸塩とその誘導体、フェノキシエタノール、ヒノキチオール、塩化ベンザルコニウム、クロルヘキシジン塩などが挙げられる。   Examples of the preservative that can be used in the present invention include, but are not limited to, parahydroxybenzoic acid esters, paraoxybenzoic acid salts and derivatives thereof, phenoxyethanol, hinokitiol, benzalkonium chloride, chlorhexidine salts, and the like. .

本発明において使用可能な等張化剤として、特に限定されるものではないが、例えば、塩化ナトリウム、塩化カリウム、塩化カルシウムなどの無機塩類が挙げられる。   The isotonic agent that can be used in the present invention is not particularly limited, and examples thereof include inorganic salts such as sodium chloride, potassium chloride, and calcium chloride.

本発明において使用可能な紫外線吸収剤として、特に限定されるものではないが、例えば、パラアミノ安息香酸、ベンゾフェノン系紫外線吸収剤、ベンゾトリアゾール系紫外線吸収剤などが挙げられる。   Although it does not specifically limit as an ultraviolet absorber which can be used in this invention, For example, a para amino benzoic acid, a benzophenone series ultraviolet absorber, a benzotriazole type ultraviolet absorber, etc. are mentioned.

本発明において使用可能なキレート剤として、特に限定されるものではないが、例えば、エチレンジアミン四酢酸、フィチン酸、クエン酸及びこれらの水溶性塩などが挙げられる。   Although it does not specifically limit as a chelating agent which can be used in this invention, For example, ethylenediaminetetraacetic acid, phytic acid, a citric acid, these water-soluble salts, etc. are mentioned.

以下、本発明を更に詳しく説明するために実施例によって説明するが、本発明はこれらの実施例により何ら限定されるものではない。
(1)植物エキスの製造方法
植物エキスは、以下の表1に示す各植物の各部位を、50質量%エタノール水溶液の環流下で1時間かけて抽出後、ろ過し、得られた抽出液から水、エタノールを減圧留去して各植物エキスを得た。得られた植物エキスを以下に示す実施例に使用した。
Hereinafter, the present invention will be described in more detail with reference to examples. However, the present invention is not limited to these examples.
(1) Production method of plant extract The plant extract is obtained by extracting each part of each plant shown in Table 1 below under reflux of a 50 mass% ethanol aqueous solution over 1 hour, followed by filtration, and from the obtained extract. Water and ethanol were distilled off under reduced pressure to obtain each plant extract. The obtained plant extract was used for the Example shown below.

Figure 2008105984
Figure 2008105984

(2)アルギン酸オリゴ糖類の製造方法
市販のアルギン酸ナトリウムであるSKAT−ULV(キミカ社製)1.5g、リン酸アンモニウム0.05g、酵母エキス0.01g、塩化ナトリウム2gをイオン交換水100g中に溶解させ、オートクレーブで2.1atm、121℃、20分間の滅菌操作を行った。滅菌処理後のアルギン酸溶液に対し、アルギン酸分解菌であるPseudo alteromonas haloplanctic(ITM 222)を一白金耳埴菌し、室温下で8時間前培養を行った。
(2) Production method of alginic acid oligosaccharide 1.5 g of commercially available sodium alginate SKAT-ULV (manufactured by Kimika), 0.05 g of ammonium phosphate, 0.01 g of yeast extract, and 2 g of sodium chloride in 100 g of ion-exchanged water Dissolved and sterilized by autoclave at 2.1 atm, 121 ° C. for 20 minutes. The alginate solution after sterilization was platinized with Pseudoalteromonas halloplastic (ITM 222), which is an alginate-degrading bacterium, and pre-cultured at room temperature for 8 hours.

次に、得られた前培溶液1mLを、アルギン酸ナトリウム分解用培地(リン酸アンモニウム0.15g、酵母エキス0.01g、アルギン酸ナトリウム(キミカ社製)9.0g、塩化ナトリウム6.0gをイオン交換水300gに溶解させ、オートクレーブで2.1atm、121℃、20分間の滅菌操作を行ったものを使用)に添加後、室温条件下で48時間振とう培養を行った。   Next, 1 mL of the obtained preculture solution was ion-exchanged with sodium alginate decomposition medium (0.15 g of ammonium phosphate, 0.01 g of yeast extract, 9.0 g of sodium alginate (manufactured by Kimika), 6.0 g of sodium chloride) It was dissolved in 300 g of water and added to an autoclave that had been sterilized at 2.1 atm, 121 ° C. for 20 minutes, and then cultured with shaking at room temperature for 48 hours.

振とう培養後のアルギン酸ナトリウム分解液から、菌体除去のために遠心分離操作(10000rpm×10分間)を行い、上澄み液を得た。得られた上澄み液に液量と同量のメタノールを加え、分解後のアルギン酸ナトリウム溶液から高分子量(数万)のアルギン酸ナトリウムを沈降させて濾別し、低分子量のアルギン酸オリゴ糖ナトリウムを含有している濾液を得た。   Centrifugation operation (10000 rpm × 10 minutes) was performed to remove bacterial cells from the sodium alginate decomposition solution after shaking culture, and a supernatant was obtained. Add the same amount of methanol to the resulting supernatant, precipitate high molecular weight (tens of thousands) sodium alginate from the decomposed sodium alginate solution, and filter and contain low molecular weight sodium alginate oligosaccharides. A filtrate was obtained.

アルギン酸オリゴ糖ナトリウムを含有している濾液の中から塩化ナトリウムなどの不純物を除去し、精製を行うために、ゲル濾過操作(Sephadex LH−20、Pharmacia Fine Chemicals)を行った。ゲル濾過操作後、得られた液を濃縮して、凍結乾燥機で乾燥を行い、目的とするアルギン酸オリゴ糖ナトリウム(平均分子量約2000)を5.4g(収率60%)得た。   To remove impurities such as sodium chloride from the filtrate containing sodium alginate oligosaccharide and perform purification, gel filtration operation (Sephadex LH-20, Pharmacia Fine Chemicals) was performed. After the gel filtration operation, the obtained liquid was concentrated and dried with a freeze dryer to obtain 5.4 g (yield 60%) of the desired sodium alginate oligosaccharide (average molecular weight: about 2000).

また、振とう培養時間を48時間から8時間に換えた以外は上記と同様に操作して、重量平均分子量約2万のアルギン酸オリゴ糖ナトリウムを得た。
更には、得られた重量平均分子量約2000のアルギン酸オリゴ糖ナトリウムをイオン交換樹脂(アンバーライト1006F H、ローム・アンド・ハース・ジャパン社製)と共に操作して、重量平均分子量約2000のアルギン酸オリゴ糖を得た。
In addition, alginate oligosaccharide sodium having a weight average molecular weight of about 20,000 was obtained in the same manner as above except that the shaking culture time was changed from 48 hours to 8 hours.
Further, the obtained sodium alginate oligosaccharide having a weight average molecular weight of about 2000 is operated together with an ion exchange resin (Amberlite 1006F H, manufactured by Rohm and Haas Japan) to obtain an alginate oligosaccharide having a weight average molecular weight of about 2000. Got.

なお、重量平均分子量の測定は、水系ゲルパーミッションクロマトグラフィー装置GPC−8020(東ソー(株)製)を用いて測定した。測定条件は、カラムにG3000(東ソー(株)製)とG5000(東ソー(株)製)を直結して用い 、カラム温度40℃、カラム流量1.0mL/min、溶出液0.1M NaCl水溶液、RI検出であり、重量平均分子量はPEG(ポリエチレングリコール)を標品として換算した値である。   The weight average molecular weight was measured using an aqueous gel permeation chromatography apparatus GPC-8020 (manufactured by Tosoh Corporation). The measurement conditions were as follows: G3000 (manufactured by Tosoh Corp.) and G5000 (manufactured by Tosoh Corp.) were directly connected to the column, column temperature 40 ° C., column flow rate 1.0 mL / min, eluent 0.1M NaCl aqueous solution, RI detection, and the weight average molecular weight is a value obtained by converting PEG (polyethylene glycol) as a standard.

得られたアルギン酸オリゴ糖ナトリウム及びアルギン酸オリゴ糖を以下に示す実施例に使用した。   The obtained sodium alginate oligosaccharide and alginate oligosaccharide were used in the following examples.

(3)アルブチン
和光純薬工業(株)製のアルブチンを以下に示す実施例に使用した。
(I)コラーゲン産生促進剤
[実施例1]
アルブチンを10mg/mLとなるよう調製し、その後、クリーンベンチ内で0.2μmのシリンジフィルターを用いて滅菌した。そして、滅菌精製水を加えて2mg/mLとなるよう調整して、培地に添加するアルブチンの希釈液を作製した。
次に、倉敷紡績(株)製の正常ヒト皮膚線維芽細胞を規定の調製法に基づき、分化、培養を行った。培地には、低血清増殖添加剤(LSGS)を添加した正常ヒト皮膚線維芽細胞増殖用低血清培地(Medium106S)を用いた。
培地に正常ヒト成人線維芽細胞(500000cell/mL)の溶液を播種し、37℃、5%−CO2、加湿のインキュベーターに入れ、1日おきに培地を交換し、6日間培養した。
6日後、シャーレから細胞をはがし、細胞浮遊液を作成した(15000cell/mL)。細胞浮遊液を24well plateに1mLずつ播種し、2日間培養した。培地交換の際、前記アルブチンの希釈液を10μL(最終濃度が20μg/mLとなる)添加し、さらに2日間培養した。2日おきに培地交換等を行い、細胞播種8日目に培地を回収した。回収した培地をTaKaRa社のProcollagen type I C−peptide(PIP)EIA Kitを使用し、その使用法に準じて、培養6日目から8日目までの48時間培養後の上清中に存在するコラーゲン前駆体タンパク質であるI型プロコラーゲンC末端プロペプチド(以下、PIPと略す)の量を測定した。このPIPはコラーゲンの量を反映するものである。
この時のPIPの量は比較例1に比べ、すなわち、コラーゲン産生促進成分(アルブチン)の希釈液の代わりに滅菌精製水を添加して、その他は同様の操作をした比較例1のPIPの量と比べると、コラーゲン産生促進能が175%であった。
(3) Arbutin Arbutin manufactured by Wako Pure Chemical Industries, Ltd. was used in the following examples.
(I) Collagen production promoter [Example 1]
Arbutin was prepared to 10 mg / mL, and then sterilized using a 0.2 μm syringe filter in a clean bench. Then, sterilized purified water was added to adjust to 2 mg / mL to prepare a diluted solution of arbutin to be added to the medium.
Next, normal human dermal fibroblasts manufactured by Kurashiki Boseki Co., Ltd. were differentiated and cultured according to a prescribed preparation method. The medium used was a low serum medium (Medium 106S) for normal human skin fibroblast proliferation supplemented with a low serum growth additive (LSGS).
The medium was seeded with a solution of normal human adult fibroblasts (500000 cells / mL), placed in a humidified incubator at 37 ° C., 5% -CO 2 , the medium was changed every other day, and cultured for 6 days.
Six days later, cells were peeled from the petri dish to prepare a cell suspension (15000 cell / mL). 1 mL of the cell suspension was seeded on a 24-well plate and cultured for 2 days. At the time of medium exchange, 10 μL of the diluted arbutin solution (final concentration becomes 20 μg / mL) was added, and further cultured for 2 days. The medium was changed every two days, and the medium was collected on the 8th day of cell seeding. The recovered medium is present in the supernatant after 48 hours of culture from the 6th day to the 8th day according to the usage method using Procollagen type I C-peptide (PIP) EIA Kit of TaKaRa. The amount of type I procollagen C-terminal propeptide (hereinafter abbreviated as PIP), which is a collagen precursor protein, was measured. This PIP reflects the amount of collagen.
The amount of PIP at this time was the same as that of Comparative Example 1, that is, the amount of PIP of Comparative Example 1 in which sterilized purified water was added instead of the diluted solution of collagen production promoting component (arbutin) and the other operations were the same. Compared with, collagen production promoting ability was 175%.

[実施例2〜37]
コラーゲン産生促進成分及び添加した最終濃度を、表2のように換えた以外は実施例1と同様の操作をして、得られたPIPの量と比較例1のPIPの量とを、同様に比較した結果を表2に示す。
[Examples 2 to 37]
The same procedure as in Example 1 was conducted except that the collagen production promoting component and the final concentration added were changed as shown in Table 2, and the amount of PIP obtained and the amount of PIP in Comparative Example 1 were similarly determined. The comparison results are shown in Table 2.

Figure 2008105984
Figure 2008105984

表2の実施例1〜37の結果が示すように、コラーゲン産生促進成分として各種植物エキス、アルブチン及びアルギン酸オリゴ糖類及びその組成物を用いたものは、正常ヒト皮膚線維芽細胞におけるコラーゲン産生に対し、有意にコラーゲン産生促進効果を示していることがわかる。   As shown in the results of Examples 1 to 37 in Table 2, those using various plant extracts, arbutin, alginic acid oligosaccharides, and compositions thereof as collagen production promoting components were effective against collagen production in normal human skin fibroblasts. It can be seen that the collagen production promotion effect is significantly exhibited.

(II)皮膚外用剤の処方例
表3〜17に示す組成でコラーゲン産生促進剤を配合した皮膚外用剤(化粧水、乳液、クリーム、リップスティック、ボディクリーム)の処方を調製した。調製方法は下記の通りである。なお、配合量の単位はgで、表中の精製水の「残量」とは全量を100gとする量である。また、リップスティックの表中のヒマシ油の「残量」も全量を100gとする量である。
(II) Formulation examples of external preparations for skin Preparations of external preparations for skin (skin lotion, emulsion, cream, lipstick, body cream) formulated with collagen production promoters with the compositions shown in Tables 3 to 17 were prepared. The preparation method is as follows. The unit of the blending amount is g, and the “remaining amount” of purified water in the table is an amount that makes the total amount 100 g. Further, the “remaining amount” of castor oil in the table of the lipstick is also an amount that makes the total amount 100 g.

化粧水(実施例38〜53、比較例2)
表3〜5のA成分、B成分のそれぞれを80℃で加温して溶解し、B成分をA成分に撹拌しながら徐々に加えて乳化した。その後、撹拌しながら冷却し、40℃でC成分を加えた後、35℃で調製を終了した。
Lotion (Examples 38-53, Comparative Example 2)
Each of A component and B component of Tables 3-5 was heated and melt | dissolved at 80 degreeC, and B component was gradually added and emulsified to A component, stirring. Then, it cooled, stirring, and after adding C component at 40 degreeC, preparation was complete | finished at 35 degreeC.

Figure 2008105984
Figure 2008105984

Figure 2008105984
Figure 2008105984

Figure 2008105984
Figure 2008105984

乳液(実施例54〜69、比較例3)
表6〜8のD成分、E成分のそれぞれを80℃に加温して溶解し、D成分をE成分に撹拌しながら加え、均一とした後、ホモミキサーで乳化した。その後、ハンドルミキサーで撹拌しながら冷却し、40℃以下でF成分を加えて、調製を終了した。
Latex (Examples 54-69, Comparative Example 3)
Each of D component and E component of Tables 6-8 was heated and melt | dissolved at 80 degreeC, it added with stirring D component to E component, and it emulsified with the homomixer after making it uniform. Then, it cooled, stirring with a handle mixer, added F component at 40 degrees C or less, and complete | finished preparation.

Figure 2008105984
Figure 2008105984

Figure 2008105984
Figure 2008105984

Figure 2008105984
Figure 2008105984

クリーム(実施例70〜85、比較例4)
表9のG成分、H成分をそれぞれ75℃に加温して溶解し、G成分をパドルミキサーで撹拌しながらH成分を少量ずつ加えた。その後、撹拌しながら冷却し、40℃でI成分を加えた後、約35℃で調製を終了した。
Cream (Examples 70 to 85, Comparative Example 4)
The G component and the H component in Table 9 were each dissolved by heating to 75 ° C., and the H component was added little by little while stirring the G component with a paddle mixer. Then, it cooled, stirring, and added I component at 40 degreeC, Then, preparation was complete | finished at about 35 degreeC.

Figure 2008105984
Figure 2008105984

Figure 2008105984
Figure 2008105984

Figure 2008105984
Figure 2008105984

リップスティック(実施例86〜101、比較例5)
表12〜14のJ成分を85℃に加温して溶解し、K成分を撹拌しながらJ成分を少量ずつ加えて均一に混合した。その後、撹拌しながら冷却し、60℃付近でL成分を加えた後、更に冷却した。その後容器に充填し、調製を終了した。
Lipstick (Examples 86 to 101, Comparative Example 5)
The J components in Tables 12 to 14 were dissolved by heating to 85 ° C., and the J component was added little by little while stirring the K component and mixed uniformly. Then, it cooled, stirring, and after adding L component at 60 degreeC vicinity, it cooled further. Thereafter, the container was filled and the preparation was completed.

Figure 2008105984
Figure 2008105984

Figure 2008105984
Figure 2008105984

Figure 2008105984
Figure 2008105984

ボディクリーム(実施例102〜117、比較例6)
表15〜17のM成分、N成分をそれぞれ75℃に加温して、M成分をパドルミキサーで撹拌しながらN成分を少量ずつ加えた。その後、撹拌しながら冷却し、45℃以下でO成分を加えて、調製を終了した。
Body cream (Examples 102 to 117, Comparative Example 6)
M component and N component of Tables 15-17 were each heated to 75 degreeC, and N component was added little by little, stirring M component with a paddle mixer. Then, it cooled, stirring, O component was added at 45 degrees C or less, and preparation was complete | finished.

Figure 2008105984
Figure 2008105984

Figure 2008105984
Figure 2008105984

Figure 2008105984
Figure 2008105984

評 価
前記実施例38〜117、比較例2〜6の皮膚外用剤について、肌のしわや張り、弾力の低下の悩みを有する30〜40代の女性を対象としたモニター試験を行い、その評価を行った。
皮膚外用剤のそれぞれについて、女性3名ずつの(17群×5処方)計255名に対して、化粧水、乳液、クリームについては1日2回(朝、夕)顔面への塗布、リップスティックについては1日3回(朝、昼、夕)口唇への塗布、ボディクリームについては1日2回(朝、夕)ボディへの塗布をすること以外は通常の生活をするモニター試験を1ヶ月間続けた。1ヶ月後、その使用感を下記の基準で評価した結果を表18に示す。なお、使用期間中に皮膚の異常を訴えたものはいなかった。
有 効 :使用前に比べて肌の張りや弾力を感じる
やや有効:使用前に比べて肌の張りや弾力をやや感じる
効果無し:使用前と変化なし
Evaluation Regarding the external preparations for skin of Examples 38 to 117 and Comparative Examples 2 to 6, a monitor test was conducted on women in their 30s and 40s who had problems of wrinkles and tension of the skin and a decrease in elasticity. Went.
For each topical skin preparation, 3 women (17 groups x 5 prescriptions) for a total of 255 people, lotions, emulsions and creams applied to the face twice a day (morning and evening), lipstick Applying to the lips three times a day (morning, noon, evening) for the skin, and one month for a monitor test for normal life except for applying the body cream to the body twice a day (morning, evening) Continued for a while. Table 18 shows the results of evaluating the feeling of use according to the following criteria after one month. None of the patients complained of skin abnormalities during the period of use.
Effective: Feels the skin tension and elasticity compared to before use Slightly effective: Feels the skin tension and elasticity slightly compared to before use No effect: No change from before use

Figure 2008105984
Figure 2008105984
Figure 2008105984
Figure 2008105984

本発明のコラーゲン産生促進剤を配合した実施例38〜117の皮膚外用剤では、各部位に張りや弾力を感じたといった人が多かった一方で、本発明のコラーゲン産生促進剤を配合していない比較例2〜6の皮膚外用剤では変化なしとの評価であったことから、本発明のコラーゲン産生促進剤を配合した皮膚外用剤は、肌あるいは口唇の張りや弾力の向上に対していずれも有意であった。   In the external preparations for skin of Examples 38 to 117 in which the collagen production promoter of the present invention was blended, there were many people who felt tension or elasticity at each site, but the collagen production promoter of the present invention was not blended. Since it was evaluated that there was no change in the external preparations for skin of Comparative Examples 2 to 6, the external preparation for skin containing the collagen production promoter of the present invention was used for improving the tension or elasticity of the skin or lips. It was significant.

(III)浴用剤の処方
次に、表19〜21に示す組成でコラーゲン産生促進剤を配合した抗老化浴用剤(入浴剤)の処方を調製した。調製法は下記の通りである。なお、配合量の単位はgで、表中の精製水の「残量」とは全量を100gとする量である。
(III) Formulation of Bath Agent Next, a formulation of an anti-aging bath agent (bath agent) having a composition shown in Tables 19 to 21 and a collagen production promoter was prepared. The preparation method is as follows. The unit of the blending amount is g, and the “remaining amount” of purified water in the table is an amount that makes the total amount 100 g.

入浴剤(実施例118〜133、比較例7)
表19〜21のP成分とQ成分をそれぞれ均一になるまで混合した後、P成分とQ成分とを混合し、均一になるまで充分混合して、調製を終了した。
Bath agent (Examples 118 to 133, Comparative Example 7)
After mixing P component and Q component of Tables 19-21 until it became uniform respectively, P component and Q component were mixed, and it mixed well until it became uniform, and preparation was complete | finished.

Figure 2008105984
Figure 2008105984

Figure 2008105984
Figure 2008105984

Figure 2008105984
Figure 2008105984

評 価
前記実施例118〜133、比較例7の入浴剤について、肌のしわや張り、弾力の低下の悩みを有する30〜40代の女性を対象としたモニター試験を行い、その評価を行った。
入浴剤のそれぞれについて、女性3名ずつの(17群)計51名に対して、毎日の入浴時にお湯180Lに対して入浴剤30mLを溶かして入浴すること以外は通常の生活をするモニター試験を1ヶ月間続けた。1ヶ月後、その使用感を下記の基準で評価した結果を表22に示す。なお、使用期間中に皮膚の異常を訴えたものはいなかった。
有 効 :使用前に比べて肌の張りや弾力を感じる
やや有効:使用前に比べて肌の張りや弾力をやや感じる
効果無し:使用前と変化なし
Evaluation Regarding the bath preparations of Examples 118 to 133 and Comparative Example 7, a monitor test was conducted on women in their 30s and 40s who have problems of wrinkles and tension of the skin and a decrease in elasticity. .
For each bathing agent, a total of 51 women (17 groups) for a total of 51 women will be able to perform a normal test, except that 30 mL of bathing agent is dissolved in 180 liters of hot water at the time of daily bathing. Continued for a month. Table 22 shows the results of evaluating the feeling of use according to the following criteria after one month. None of the patients complained of skin abnormalities during the period of use.
Effective: Feels the skin tension and elasticity compared to before use Slightly effective: Feels the skin tension and elasticity slightly compared to before use No effect: No change from before use

Figure 2008105984
Figure 2008105984

本発明のコラーゲン産生促進剤を配合した実施例118〜133の入浴剤では、肌に張りや弾力を感じたといった人が多かった一方で、本発明のコラーゲン産生促進剤を配合していない比較例7の入浴剤では変化なしとの評価であったことから、本発明のコラーゲン産生促進剤を配合した入浴剤は、肌の張りや弾力の向上に対しいずれも有意であった。   In the bath preparations of Examples 118 to 133 in which the collagen production promoter of the present invention was blended, there were many people who felt tension and elasticity on the skin, but comparative examples in which the collagen production promoter of the present invention was not blended. Since it was evaluated that there was no change in the bathing agent of No. 7, the bathing agent containing the collagen production accelerator of the present invention was significant for improving the skin tension and elasticity.

(IV)飲食物の処方
次に、表23〜30に示す組成でコラーゲン産生促進剤を配合した抗老化飲食物(パン、ゼリー、ソーセージ、サプリメント(錠剤))の処方を調製した。調製法は下記の通りである。なお、配合量の単位はgで、表中の精製水の「残量」とは全量を100gとする量である。
(IV) Food / Beverage Formulation Next, a formulation of anti-aging food / beverage (bread, jelly, sausage, supplement (tablet)) blended with a collagen production promoter with the composition shown in Tables 23 to 30 was prepared. The preparation method is as follows. The unit of the blending amount is g, and the “remaining amount” of purified water in the table is an amount that makes the total amount 100 g.

パン(実施例134〜141、比較例8)
表23及び24のR成分全部を混ぜ合わせたものに、40℃に加温したS成分とT成分を混ぜ合わせたもの加えて、均一になった時点でよくこねた。35℃で40分間一次発酵させ、空気を抜くように再度こねた。40℃で40分間二次発酵後、180℃で25分間焼いた。
Bread (Examples 134 to 141, Comparative Example 8)
A mixture of all the R components in Tables 23 and 24 was added to the mixture of the S and T components heated to 40 ° C., and kneaded well when the mixture became uniform. Primary fermentation was performed at 35 ° C. for 40 minutes, and kneaded again so as to remove air. After secondary fermentation at 40 ° C. for 40 minutes, baking was performed at 180 ° C. for 25 minutes.

Figure 2008105984
Figure 2008105984

Figure 2008105984
Figure 2008105984

ゼリー(実施例142〜149、比較例9)
表25及び26のW成分にV成分を溶解した80℃のお湯にU成分を溶かし、よく混ぜ合わせた。型に10gずつ流し入れた後、冷蔵庫で固めて、調製を終了した。
Jelly (Examples 142-149, Comparative Example 9)
The U component was dissolved in 80 ° C. hot water in which the V component was dissolved in the W component in Tables 25 and 26 and mixed well. After pouring 10 g into the mold, it was hardened in a refrigerator to complete the preparation.

Figure 2008105984
Figure 2008105984

Figure 2008105984
Figure 2008105984

ソーセージ(実施例150〜157、比較例10)
表27及び28のX成分とY成分とを良く混ぜ合わせ、冷蔵庫で冷やした後、塩抜きした羊の腸に詰めた。腸詰めしたものを60〜70℃で1時間燻製し、更に1時間かけて乾燥させた。乾燥させたものを約70℃のお湯で30分程度ゆでて殺菌処理した。そして再度乾燥させて、調製を終了した。
Sausage (Examples 150 to 157, Comparative Example 10)
The X component and Y component in Tables 27 and 28 were mixed well, cooled in a refrigerator, and then packed in the intestines of salted sheep. The intestinal stuffed product was smoked at 60 to 70 ° C. for 1 hour and further dried for 1 hour. The dried product was boiled with hot water of about 70 ° C. for about 30 minutes and sterilized. And it dried again, and preparation was complete | finished.

Figure 2008105984
Figure 2008105984

Figure 2008105984
Figure 2008105984

サプリメント(錠剤)(実施例158〜165、比較例11)
表29及び30のAA成分とAB成分を良く混ぜ合わせたものを、打錠機を用いてタブレット状に押し固め、錠剤(0.3g)を形成した。
Supplement (Tablet) (Examples 158 to 165, Comparative Example 11)
A mixture of the AA component and the AB component in Tables 29 and 30 was mixed into tablets using a tableting machine to form tablets (0.3 g).

Figure 2008105984
Figure 2008105984

Figure 2008105984
Figure 2008105984

評 価
前記実施例134〜165、比較例7〜11の飲食物について、肌のしわや張り、弾力の低下の悩みを有する30〜40代の女性を対象としたモニター試験を行い、その評価を行った。
飲食物のそれぞれについて、女性3名ずつの(9群×4処方)計108名に対して、パンについては、毎日の朝食時に前記実施例又は比較例のパンを主食として90g食べること、ゼリーについては、毎日の夕食後に前記実施例又は比較例のゼリーを50g摂取すること、ソーセージについては、毎日の夕食時に前記実施例又は比較例のソーセージを副食として約60g食べること、サプリメント(錠剤)については、毎日3回の食事後に前記実施例又は比較例のサプリメント(錠剤)を5錠(1.5g)摂取すること以外は通常の生活をするモニター試験を1ヶ月間続けた。1ヶ月後、その使用感を下記の基準で評価した結果を表31に示す。なお、使用期間中に皮膚の異常を訴えたものはいなかった。
有 効 :使用前に比べて肌の張りや弾力を感じる
やや有効:使用前に比べて肌の張りや弾力をやや感じる
効果無し:使用前と変化なし
Evaluation Regarding the food and drink of Examples 134 to 165 and Comparative Examples 7 to 11, a monitor test was conducted for women in their 30s and 40s who have worries about skin wrinkles and tension and a decrease in elasticity. went.
For each food and drink, 3 women (9 groups x 4 prescriptions) for a total of 108 people, for bread, eat 90g of the above example or comparative example bread as a staple food at the time of daily breakfast, about jelly Ingesting 50 g of the jelly of the above example or comparative example after dinner every day, about sausage, eating about 60 g of the sausage of the example or comparative example as a side meal at dinner every day, about supplements (tablets) The monitoring test for normal life was continued for one month except that 5 supplements (1.5 g) of the supplements (tablets) of the examples or comparative examples were taken 3 times daily. Table 31 shows the results of evaluating the feeling of use according to the following criteria after one month. None of the patients complained of skin abnormalities during the period of use.
Effective: Feels the skin tension and elasticity compared to before use Slightly effective: Feels the skin tension and elasticity slightly compared to before use No effect: No change from before use

Figure 2008105984
Figure 2008105984

本発明のコラーゲン産生促進剤を配合した実施例134〜165の飲食物では、肌に張りや弾力を感じたといった人が多かった一方で、本発明のコラーゲン産生促進剤を配合していない比較例8〜11の飲食物では変化なしとの評価であったことから、本発明のコラーゲン産生促進剤を配合した飲食物は、肌の張りや弾力の向上に対しいずれも有意であった。   In the foods and drinks of Examples 134 to 165 blended with the collagen production promoter of the present invention, there were many people who felt tension and elasticity on the skin, but comparative examples not blended with the collagen production promoter of the present invention. Since it was evaluation that there was no change in the foods and drinks of 8-11, all the foods and drinks which mix | blended the collagen production promoter of this invention were significant with respect to the improvement of skin tension and elasticity.

クララエキス、イトヒメハギエキス、カキエキス、タンジンエキス、シャクヤクエキス、プーアルエキス、アルブチン又はアルギン酸オリゴ糖類及びこれらの混合物は、コラーゲン産生を促進させる作用があり、コラーゲン産生促進剤として有用である。本発明のコラーゲン産生促進剤は、線維芽細胞において産生されるコラーゲンの量を増大させるので、その結果として、しわ、たるみの予防、緩和、改善がなされて、老化現象の防止、改善を目的とした化粧品をはじめとする各種の皮膚外用剤、浴用剤及び飲食物などへの利用が可能となる。   Clara extract, citrus extract, oyster extract, tanjin extract, peony extract, puer extract, arbutin or alginic acid oligosaccharide and a mixture thereof have an action of promoting collagen production and are useful as a collagen production promoter. The collagen production promoter of the present invention increases the amount of collagen produced in fibroblasts. As a result, wrinkles and sagging can be prevented, alleviated, and improved, with the aim of preventing and improving the aging phenomenon. It can be used for various skin external preparations such as cosmetics, bath preparations and foods and drinks.

Claims (4)

クララエキス、イトヒメハギエキス、カキエキス、タンジンエキス、シャクヤクエキス、プーアルエキス、アルブチン及びアルギン酸オリゴ糖類から選ばれる1種又は2種以上を含有することを特徴とするコラーゲン産生促進剤。   A collagen production promoter characterized by containing one or more selected from Clara extract, Cypress extract, Oyster extract, Tanjin extract, Peonies extract, Pual extract, Arbutin and Alginate oligosaccharide. 請求項1に記載のコラーゲン産生促進剤を含有することを特徴とする皮膚外用剤。   An external preparation for skin, comprising the collagen production promoter according to claim 1. 請求項1に記載のコラーゲン産生促進剤を含有することを特徴とする浴用剤。   A bath preparation comprising the collagen production promoter according to claim 1. 請求項1に記載のコラーゲン産生促進剤を含有することを特徴とする飲食物。   A food or drink comprising the collagen production promoter according to claim 1.
JP2006289308A 2006-10-25 2006-10-25 Collagen production promoter, skin care preparation for external use, bathing agent, and food and drink Withdrawn JP2008105984A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006289308A JP2008105984A (en) 2006-10-25 2006-10-25 Collagen production promoter, skin care preparation for external use, bathing agent, and food and drink

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006289308A JP2008105984A (en) 2006-10-25 2006-10-25 Collagen production promoter, skin care preparation for external use, bathing agent, and food and drink

Publications (1)

Publication Number Publication Date
JP2008105984A true JP2008105984A (en) 2008-05-08

Family

ID=39439639

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006289308A Withdrawn JP2008105984A (en) 2006-10-25 2006-10-25 Collagen production promoter, skin care preparation for external use, bathing agent, and food and drink

Country Status (1)

Country Link
JP (1) JP2008105984A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008105983A (en) * 2006-10-25 2008-05-08 Nicca Chemical Co Ltd Fibroblast proliferation promoter, skin care preparation for external use, bathing agent, and food and drink
JP2008105985A (en) * 2006-10-25 2008-05-08 Nicca Chemical Co Ltd Hyaluronic acid production promoter, skin care preparation for external use, bathing agent, and food and drink
FR2958164A1 (en) * 2010-04-01 2011-10-07 Silab Sa Use of an active ingredient derived from calyx of Diospyros kaki with specified amount of phenolic content, as antistress and antiaging agent in a cosmetic composition
US20140155244A1 (en) * 2012-07-03 2014-06-05 Tomoe Engineering Co., Ltd. Sludge processing system and storage medium storing a program for controlling an operation of a sludge processing system thereon
CN112402319A (en) * 2020-11-30 2021-02-26 北京金莎科技有限公司 Nutrient solution for improving skin quality and preparation and use methods thereof
CN114886800A (en) * 2022-06-29 2022-08-12 水羊化妆品制造有限公司 Application of dark green tea polysaccharide

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008105983A (en) * 2006-10-25 2008-05-08 Nicca Chemical Co Ltd Fibroblast proliferation promoter, skin care preparation for external use, bathing agent, and food and drink
JP2008105985A (en) * 2006-10-25 2008-05-08 Nicca Chemical Co Ltd Hyaluronic acid production promoter, skin care preparation for external use, bathing agent, and food and drink
FR2958164A1 (en) * 2010-04-01 2011-10-07 Silab Sa Use of an active ingredient derived from calyx of Diospyros kaki with specified amount of phenolic content, as antistress and antiaging agent in a cosmetic composition
US20140155244A1 (en) * 2012-07-03 2014-06-05 Tomoe Engineering Co., Ltd. Sludge processing system and storage medium storing a program for controlling an operation of a sludge processing system thereon
US20140155245A1 (en) * 2012-07-03 2014-06-05 Tomoe Engineering Co., Ltd. Sludge processing system and storage medium storing a program for controlling an operation of a sludge processing system thereon
US9206064B2 (en) * 2012-07-03 2015-12-08 Tomoe Engineering Co., Ltd. Sludge processing system and storage medium storing a program for controlling operation of a sludge processing system based on correlation between moisture content of concentrated sludge, centrifugal force, and concentrated sludge convey torque
US9212076B2 (en) * 2012-07-03 2015-12-15 Tomoe Engineering Co., Ltd. Sludge processing system and storage medium storing a program for controlling operation of a sludge processing system based on moisture content of concentrated sludge
CN112402319A (en) * 2020-11-30 2021-02-26 北京金莎科技有限公司 Nutrient solution for improving skin quality and preparation and use methods thereof
CN114886800A (en) * 2022-06-29 2022-08-12 水羊化妆品制造有限公司 Application of dark green tea polysaccharide

Similar Documents

Publication Publication Date Title
JP2008105983A (en) Fibroblast proliferation promoter, skin care preparation for external use, bathing agent, and food and drink
JP2008105985A (en) Hyaluronic acid production promoter, skin care preparation for external use, bathing agent, and food and drink
JP5913118B2 (en) Collagen production promoter, hyaluronic acid production promoter, fibroblast proliferation promoter, and anti-wrinkle agent
JP2003300858A (en) Skin care preparation
JP4091824B2 (en) Skin preparation
JPWO2007011066A1 (en) Fibroblast activator, collagen production promoter, collagen contraction promoter, hyaluronic acid production promoter, ATP production promoter, melanin production inhibitor, skin external preparation
JP2008105984A (en) Collagen production promoter, skin care preparation for external use, bathing agent, and food and drink
JP2008088075A (en) Profilaggrin/filaggrin production promoter, epidermal keratinocyte proliferation promoter, skin care preparation for normalizing epidermis/horny cell layer, profilaggrin/filaggrin production-promoting method and epidermal keratinocyte proliferation-promoting method
JP2006265120A (en) Collagen synthesis accelerator
WO2011093418A1 (en) Agent for promoting differentiation of adipocyte precursor cells
JPH1029924A (en) Antiaging agent
JP2011195537A (en) Antioxidant, whitening agent, anti-aging agent, hair tonic, humectant, skin care preparation and functional oral composition
JP5366358B2 (en) Agent for acting on skin aging mechanism, anti-aging skin external preparation, and anti-aging method
JP5711879B2 (en) Fibroblast growth factor-7 production promoter, scalp / hair cosmetic containing the same, and food and drink
JP5171752B2 (en) Topical skin preparation
JP2013010693A (en) Mitf-m production promoter, and hair cosmetic composition and skin cosmetic composition comprising the mitf-m production promoter
JP5155543B2 (en) Endothelin-1 production inhibitor, hexosaminidase release inhibitor, anti-inflammatory / whitening skin preparation, endothelin-1 production inhibition method, and hexosaminidase release inhibition method
JP2009249366A (en) Collagen production promotor and anti-aging skin preparation for external use
JP2021187787A (en) Exosome secretagogue, exosome uptake promoter, exosome secretion-promoting beauty composition, and exosome secretion promoting method
JP2009256326A (en) Skin whitening preparation, and skincare preparation
JP5932948B2 (en) Fibroblast growth factor-7 production promoter, scalp / hair cosmetic containing the same, and food and drink
JP2005272444A (en) External preparation for skin
JP7349076B2 (en) Melanin production inhibitors and skin whitening agents or skin external preparations containing the same
JPH08133959A (en) Skin cosmetic
KR20070121193A (en) Composition for protection or anti-inflammation containing one or more among rice wine extract and rice wine lees extract

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090828

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20111028